Free Trial

RadNet (RDNT) Competitors

RadNet logo
$49.25 -0.46 (-0.93%)
Closing price 03/21/2025 04:00 PM Eastern
Extended Trading
$49.50 +0.25 (+0.51%)
As of 03/21/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

RDNT vs. FMS, HIMS, OPCH, GH, SHC, SGRY, BTSG, PRVA, CON, and LFST

Should you be buying RadNet stock or one of its competitors? The main competitors of RadNet include Fresenius Medical Care (FMS), Hims & Hers Health (HIMS), Option Care Health (OPCH), Guardant Health (GH), Sotera Health (SHC), Surgery Partners (SGRY), BrightSpring Health Services (BTSG), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), and LifeStance Health Group (LFST). These companies are all part of the "healthcare" industry.

RadNet vs.

Fresenius Medical Care (NYSE:FMS) and RadNet (NASDAQ:RDNT) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, profitability, valuation, community ranking, analyst recommendations, dividends, earnings, media sentiment and risk.

Fresenius Medical Care received 69 more outperform votes than RadNet when rated by MarketBeat users. However, 66.17% of users gave RadNet an outperform vote while only 54.72% of users gave Fresenius Medical Care an outperform vote.

CompanyUnderperformOutperform
Fresenius Medical CareOutperform Votes
423
54.72%
Underperform Votes
350
45.28%
RadNetOutperform Votes
354
66.17%
Underperform Votes
181
33.83%

Fresenius Medical Care presently has a consensus price target of $25.30, indicating a potential upside of 4.18%. RadNet has a consensus price target of $76.75, indicating a potential upside of 55.84%. Given RadNet's stronger consensus rating and higher possible upside, analysts plainly believe RadNet is more favorable than Fresenius Medical Care.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fresenius Medical Care
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33
RadNet
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
2 Strong Buy rating(s)
3.40

Fresenius Medical Care has higher revenue and earnings than RadNet. Fresenius Medical Care is trading at a lower price-to-earnings ratio than RadNet, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fresenius Medical Care$19.34B0.74$540.07M$0.9924.53
RadNet$1.83B1.99$3.04M$0.031,641.67

In the previous week, RadNet had 6 more articles in the media than Fresenius Medical Care. MarketBeat recorded 13 mentions for RadNet and 7 mentions for Fresenius Medical Care. Fresenius Medical Care's average media sentiment score of 1.04 beat RadNet's score of 1.02 indicating that Fresenius Medical Care is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Fresenius Medical Care
2 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
RadNet
8 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Fresenius Medical Care has a beta of 0.99, indicating that its share price is 1% less volatile than the S&P 500. Comparatively, RadNet has a beta of 1.85, indicating that its share price is 85% more volatile than the S&P 500.

8.4% of Fresenius Medical Care shares are owned by institutional investors. Comparatively, 77.9% of RadNet shares are owned by institutional investors. 5.1% of RadNet shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Fresenius Medical Care has a net margin of 3.43% compared to RadNet's net margin of -0.25%. Fresenius Medical Care's return on equity of 6.04% beat RadNet's return on equity.

Company Net Margins Return on Equity Return on Assets
Fresenius Medical Care3.43% 6.04% 2.69%
RadNet -0.25%4.29%1.45%

Summary

RadNet beats Fresenius Medical Care on 10 of the 19 factors compared between the two stocks.

Remove Ads
Get RadNet News Delivered to You Automatically

Sign up to receive the latest news and ratings for RDNT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RDNT vs. The Competition

MetricRadNetMedical laboratories IndustryMedical SectorNASDAQ Exchange
Market Cap$3.65B$2.91B$5.73B$8.13B
Dividend YieldN/A21.62%4.39%4.04%
P/E Ratio-703.4713.4524.7419.07
Price / Sales1.99209.60398.9891.58
Price / Cash18.8157.5638.1634.64
Price / Book4.184.697.104.43
Net Income$3.04M-$22.21M$3.20B$247.36M
7 Day Performance5.82%3.98%1.98%1.98%
1 Month Performance-17.19%-9.02%3.59%-6.10%
1 Year Performance2.52%3.61%14.49%3.48%

RadNet Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RDNT
RadNet
4.2411 of 5 stars
$49.25
-0.9%
$76.75
+55.8%
+2.5%$3.65B$1.83B-703.478,970Analyst Upgrade
Insider Trade
News Coverage
Positive News
High Trading Volume
FMS
Fresenius Medical Care
3.4906 of 5 stars
$24.18
+0.6%
$25.30
+4.6%
+29.6%$14.20B$19.34B19.991,358Positive News
Gap Down
HIMS
Hims & Hers Health
2.176 of 5 stars
$34.68
+4.6%
$37.23
+7.4%
+112.9%$7.74B$1.48B79.141,046Analyst Forecast
Insider Trade
OPCH
Option Care Health
4.137 of 5 stars
$33.88
+3.7%
$33.00
-2.6%
+5.8%$5.59B$5.00B28.445,600Positive News
GH
Guardant Health
3.6618 of 5 stars
$42.94
+0.1%
$48.40
+12.7%
+167.2%$5.34B$739.02M-12.161,790
SHC
Sotera Health
2.7718 of 5 stars
$11.93
+3.0%
$15.92
+33.4%
+5.3%$3.39B$1.10B47.833,000Positive News
SGRY
Surgery Partners
2.6867 of 5 stars
$24.41
+3.4%
$36.63
+50.1%
-12.9%$3.12B$3.11B-50.9113,500
BTSG
BrightSpring Health Services
2.3577 of 5 stars
$17.43
+0.1%
$21.67
+24.3%
+87.8%$3.05B$11.27B-67.0335,000
PRVA
Privia Health Group
3.7134 of 5 stars
$23.22
-2.2%
$26.67
+14.9%
+19.0%$2.79B$1.74B231.231,102Analyst Forecast
Positive News
CON
Concentra Group Holdings Parent
N/A$21.04
+1.2%
$28.38
+34.8%
N/A$2.69B$1.90B13.9811,000Ex-Dividend
Analyst Forecast
News Coverage
Positive News
LFST
LifeStance Health Group
2.3626 of 5 stars
$6.89
-0.5%
$8.63
+25.3%
+15.5%$2.66B$1.25B-26.569,325Insider Trade
Positive News
Remove Ads

Related Companies and Tools


This page (NASDAQ:RDNT) was last updated on 3/24/2025 by MarketBeat.com Staff
From Our Partners